权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Cellular and microenvironmental mechanisms linking aging to tumor control

将衰老与肿瘤控制联系起来的细胞和微环境机制

基本信息

批准号：
10348456
负责人：
Alison Epstein Ringel
金额：
$ 16.2万
依托单位：
MASSACHUSETTS GENERAL HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-07-11 至 2025-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10348456
关键词：
Affect Age Aging Applications Grants Atlases Bacterial Infections Beds Bioenergetics Biological Models CD8-Positive T-Lymphocytes Cancer Model Cancer Research Project Cell Culture Techniques Cell physiology Cells Data Development Plans Doctor of Philosophy Elderly Environmental Impact Environmental Risk Factor Enzymes Faculty Fatty acid glycerol esters Flow Cytometry Functional disorder Future Genes Genetic Transcription Goals Growth Heterogeneity Immune Immune response Immune system Impairment In Vitro Incidence Interview Laboratories Lead Life Expectancy Link Lipids Malignant Neoplasms Manuscripts Maps Measures Mediating Mentors Metabolic Metabolic Pathway Modeling Molecular Mus Mutation Newly Diagnosed Normal tissue morphology Obese Mice Obesity Pathway interactions Patients Physiology Population Positioning Attribute Postdoctoral Fellow Prevention therapy Process Publishing Research Research Proposals Risk Factors Role Stress Stromal Cells Systems Biology T-Cell Activation T-Cell Proliferation T-Lymphocyte Testing Therapeutic Time Tumor Immunity Virus Diseases Work age effect age related aged anticancer research base cancer cell cancer diagnosis cancer prevention cancer risk cancer therapy career cell age cell killing cell type comparative diet-induced obesity environment related cancer functional decline healthy aging human old age (65+)immune function improved in vivo innovation insight lipid biosynthesis lipid mediator lipidomics medical schools metabolomics mouse model neoplastic cell overexpression patient population pre-clinical programs response single-cell RNA sequencing tenure track transcriptomics tumor tumor growth tumor immunology tumor microenvironment tumor progression tumorigenesis young adult

项目摘要

Project Summary. Research. Cancer incidence increases dramatically with age. While the average life expectancy continues to rise, one consequence is that cancer cases are predicted to grow by 45% between 2010 and 2030, highlighting the critical need to study the intersection between aging physiology and tumorigenesis. However, the majority of cancer research is performed using young adult mice as pre-clinical cancer models, where impact of environmental risk factors, like aging, on key features of tumorigenesis cannot be measured. The immune system is especially vulnerable to functional decline with aging. Many different kinds of immune cells can be found infiltrating tumors, where CD8+ T cells in particular can identify and selectively kill cancer cells by recognizing tumor features that differ from normal tissue. Although studies have shown that aging diminishes CD8+ T cell proliferation and effector responses following bacterial and viral infections, the role of aging on anti- tumor immunity is still a major black box. Based on our preliminary data in tumors from young and aged mice, we hypothesize that impaired anti-tumor immunity by CD8+ T cells contributes to tumorigenesis during aging. To test this hypothesis, Aim 1 will first develop mouse models to study aging, cancer, and anti-tumor immunity, and then identify mechanisms that alter immune cell function in the tumor niche using flow cytometry and single cell RNA-sequencing. In Aim 2, we will define metabolic changes in the aged tumor microenvironment and then test whether these are causal for CD8+ T cell dysfunction. Finally, Aim 3 will determine whether enhancing metabolic pathways in immune cells identified by transcriptomic and metabolomic analysis can improve tumor control during aging. By revealing how the tumor microenvironment changes with age and the impact on anti-tumor immunity, these studies will identify mechanisms that drive T cell dysfunction in tumors that may be targeted to improve cancer prevention and therapy. Candidate. Dr. Alison Ringel, PhD, is the PI for this research proposal. She has worked as a postdoctoral fellow for the past five years at Harvard Medical School, where she has sought to understand the molecular mechanisms that drive tumorigenesis in response to environmental cancer risk factors such as obesity. She is in the process of interviewing for tenure-track faculty positions and has mapped out a detailed professional development plan that will enable her to transition to an independent research career where she will develop her research program on aging and tumorigenesis. She aims to become a leader in cancer immunology by applying an innovative systems biology approach to dissect the tumor niche, which will distinguish her independent work from that of her postdoctoral mentors. Her long-term goal is to lead an independent cancer research program dedicated to the discovery of molecular mechanisms within tumors that regulate local immune responses and tumor progression.

项目总结。